arrow_back Back to App

Increased Funding for Charcot-Marie-Tooth Disease Research

This House of Representatives resolution highlights the significance of Charcot-Marie-Tooth disease (CMT), affecting thousands of Americans, and calls for increased research funding. The aim is to accelerate the search for a cure and better treatments, potentially improving the quality of life for those suffering from this rare condition.
Key points
Recognizing Charcot-Marie-Tooth disease as a significant condition impacting many people.
Calling for robust funding for CMT research at the National Institute of Neurological Disorders and Stroke.
Emphasizing the need for continued investment in research for rare diseases with no cure.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HRES_1039
Sponsor: Rep. Gottheimer, Josh [D-NJ-5]
Process start date: 2024-02-29
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HRES_1039.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-02-29.

What are the main provisions?

Key points include:

  • Recognizing Charcot-Marie-Tooth disease as a significant condition impacting many people.
  • Calling for robust funding for CMT research at the National Institute of Neurological Disorders and Stroke.
  • Emphasizing the need for continued investment in research for rare diseases with no cure.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Gottheimer, Josh [D-NJ-5].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health